Related Experiment Video

Updated: Jun 7, 2026

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

BRAF inactivation drives aneuploidy by deregulating CRAF

Tamihiro Kamata1, Jahan Hussain, Susan Giblett

  • 1Department of Biochemistry, University of Leicester, Leicester, United Kingdom.

Cancer Research
|October 28, 2010
PubMed

Insights

Mutant BRAF Aspartate-594, though kinase inactive, promotes cancer by inducing aneuploidy (abnormal chromosome number) via Craf activation. This finding links Craf to chromosomal instability, impacting cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Aspartate-594 is a common BRAF mutation in human cancers, but its role is unclear as mutants are kinase inactive.
  • Understanding how kinase-inactive BRAF mutants contribute to cancer is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the mechanism by which the BRAF Aspartate-594 mutant (D594A) contributes to cancer development.
  • To determine the role of Craf and the MEK/ERK pathway in the D594A-induced phenotype.

Main Methods:

  • Utilized a conditional knock-in mouse model expressing the (D594A)Braf mutant.
  • Assessed aneuploidy in murine splenocytes and mouse embryonic fibroblasts.
  • Investigated the involvement of Craf and the MEK/ERK pathway using specific inhibitors.

Main Results:

  • The (D594A)Braf mutant did not directly drive tumor development but induced aneuploidy.
  • Aneuploidy was dependent on the related gene product Craf.
  • MEK inhibitor U0126 prevented the growth of aneuploid cells but not their emergence.

Conclusions:

  • The BRAF D594A mutant contributes to cancer by inducing aneuploidy through Craf.
  • This study reveals a novel link between Craf and chromosomal stability.
  • Findings have implications for understanding cancers with BRAF mutations that hyperactivate Craf.

More Related Videos

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...